Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in Tricuspid Valve Surgery
NCT05233202Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levosimendan in low cardiac output syndrome (LCOS), Right ventricular dysfunction (RVD), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
levosimendan
03
Conditions
low cardiac output syndrome (LCOS)Right ventricular dysfunction (RVD)
Beyond the preview
Go deeper on NCT05233202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05233202.